Nolan Sigal's most recent trade in Rein Therapeutics Inc. was a trade of 96,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 15, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rein Therapeutics Inc. | Nolan Sigal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 96,000 | 96,000 | - | - | Stock Option (right to buy) |